RT Journal Article
SR Electronic
T1 Enhancing Thyroid Nodule Assessment: Leveraging Contrast-Enhanced Ultrasonography as a Screening Modality - A Meta-Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.11.24304174
DO 10.1101/2024.08.11.24304174
A1 Desai, Dev
A1 Malafi, Maria Eleni
A1 Shah, Hetvi
A1 Parikh, Aneri
A1 Shah, Abhijay B
A1 Gami, Vismit
A1 Gupta, Parth
YR 2024
UL http://medrxiv.org/content/early/2024/08/14/2024.08.11.24304174.abstract
AB Introduction: - CEUS has become an emerging radio diagnostic technique of modern times. The use of these contrasts offers a way better alternative than materials that cause radiation. Thyroid nodules are notorious for their effect on normal physiology and the routine best diagnostic modality apart from biopsy is Radioactive Iodine. Aim:- To conduct a diagnostic test accuracy meta-analysis to understand the role of CEUS in diagnosing thyroid nodules. Methodology:- According to Prisma guidelines, literature on the topic was found using the Keywords CEUS, Thyroid Nodule, and Radioactive Iodine. Two independent reviewers conducted a quality check on the papers and decided on the studies that should be included. Any discrepancies were solved by a third reviewer. Meta Disc, Review Manager, and Excel were used to analyze the extracted data from the selected studies as per the inclusion and exclusion criteria. Biopsy was taken as a Reference Gold Standard. Result:- A total of 47 RCTs with 5,527 patients were selected for the study. The pooled sensitivity of CEUS is 0.87, with a CI of 95% in a range of 0.86 to 0.88. The specificity of CEUS is 0.84, with a CI of 95% in a range of 0.82 to 0.85. The summary of the ROC curve shows that the area under the curve for CEUS was 0.9292 and the overall diagnostic odds ratio (DOR) was 40.59. Conclusion:- It can be concluded from the results that CEUS can be used as a Screening tool for high suspicion groups but it is still not a perfect test. The newer generation of Contrasts may yield higher accuracy but for the currently available contrasts, Biopsy remains the best tool for a definitive and accurate diagnosis. Keywords:- Thyroid Nodule, Contrast-Enhanced Ultrasound, Benign, Malignant, PrognosisCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The article being a meta analysis has used data from already conducted papers. All these papers have been cited and referenced appropriately.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript